SEC Form SC 13G filed by Flora Growth Corp.
$FLGC
Biotechnology: Pharmaceutical Preparations
Health Care
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G
INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
Flora Growth Corp.
|
|
(Name of Issuer)
|
|
Common Shares, no par value |
|
(Title of Class of Securities)
|
|
339764201
|
|
(CUSIP Number)
|
|
April 22, 2024
|
|
(Date of Event Which Requires Filing of This Statement)
|
Check the Appropriate box to designate the rule pursuant to which this schedule is filed:
Rule 13d-1(b)
X Rule 13d-1(c)
Rule 13d-1(d)
|
1
|
NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
|
||
|
RDS Private Capital II, LP
|
|||
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) X
(b) |
||
|
|
|||
|
3
|
SEC USE ONLY
|
||
|
|
|||
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
||
|
Ontario, Canada
|
|||
|
5
|
SOLE VOTING POWER
|
||
|
NUMBER OF
|
0
|
||
|
SHARES
|
6
|
SHARED VOTING POWER
|
|
|
BENEFICIALLY
|
940,145
|
||
|
OWNED BY
|
7
|
SOLE DISPOSITIVE POWER
|
|
|
EACH
|
0
|
||
|
REPORTING
|
8
|
SHARED DISPOSITIVE POWER
|
|
|
PERSON WITH
|
940,145
|
||
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
||
|
940,145
|
|||
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* q
|
||
|
|
|||
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
|
||
|
7.34%
|
|||
|
12
|
TYPE OF REPORTING PERSON*
|
||
|
PN
|
|||
*SEE INSTRUCTIONS BEFORE FILLING OUT!
|
1
|
NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
|
||
|
Ronald D. Schmeichel
|
|||
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) X
(b) |
||
|
|
|||
|
3
|
SEC USE ONLY
|
||
|
|
|||
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
||
|
Canadian
|
|||
|
5
|
SOLE VOTING POWER
|
||
|
NUMBER OF
|
314,132
|
||
|
SHARES
|
6
|
SHARED VOTING POWER
|
|
|
BENEFICIALLY
|
940,145
|
||
|
OWNED BY
|
7
|
SOLE DISPOSITIVE POWER
|
|
|
EACH
|
314,132
|
||
|
REPORTING
|
8
|
SHARED DISPOSITIVE POWER
|
|
|
PERSON WITH
|
940,145
|
||
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
||
|
1,254,277
|
|||
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* q
|
||
|
|
|||
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
|
||
|
9.79%(2)
|
|||
|
12
|
TYPE OF REPORTING PERSON*
|
||
|
IN
|
|||
Item 1 (a). Name of Issuer:
Flora Growth Corp.
Item 1 (b). Address of Issuer’s Principal Executive Offices:
3230 W. Commercial Boulevard, Suite 180
Fort Lauderdale, FL 33309
Fort Lauderdale, FL 33309
Item 2 (a). Name of Person Filing:
|
i)
|
RDS Private Capital II, LP
|
|
ii)
|
Ronald D. Schmeichel
|
Item 2 (b). Address of Principal Business Office or, if None, Residence:
135 Yorkville Avenue, Suite 900
Toronto, Ontario M5R 0C7 Canada
Toronto, Ontario M5R 0C7 Canada
Item 2 (c). Citizenship:
Ontario, Canada
Item 2 (d). Title of Class of Securities:
Common Shares, no par value
Item 2 (e). CUSIP Number:
339764201
| Item 3. |
If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
|
|
(a)
|
Broker or dealer registered under Section 15 of the Act;
|
| (b) |
Bank as defined in Section 3(a)(6) of the Act;
|
| (c) |
Insurance Company as defined in Section 3(a)(19) of the Act;
|
| (d) |
Investment Company registered under Section 8 of the Investment Company Act;
|
| (e) |
Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
|
| (f) |
Employee benefit plan or endowment plan in accordance with Rule 13d-1(b)(1)(ii)(F);
|
| (g) |
Parent holding company or control person, in accordance with Rule 13d-1(b)(1)(ii)(G);
|
| (h) |
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
|
|
(i)
|
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of
1940:
|
| (j) |
Group, in accordance with Rule 13d-1(b)(1)(ii)(j).
|
| S |
If this statement is filed pursuant to Rule 13d-1(c), check this box.
|
| Item 4. |
Ownership.
|
Provide the following information regarding the aggregate number and percentage of the class of securities identified in
Item 1.
| (a) |
Amount beneficially owned:
1,254,277 |
| (b) |
Percent of class:
|
9.79%
|
(b)
|
Number of shares as to which such person has:
|
|
(i)
|
Sole power to vote or to direct the vote: 0
|
(ii) Shared power to vote or to direct the vote: 1,254,277
(iii) Sole power to dispose or to direct the disposition of: 0
(iv) Shared power to dispose or to direct the disposition of: 1,254,277
|
(1)
|
Ronald D. Schmeichel is the manager of RDS Private Capital II, LP
|
|
(2)
|
Percent of class is based on 12,816,535 outstanding shares of common stock of the Issuer as of May 10, 2024.
|
Instruction. For computations regarding securities which
represent a right to acquire an underlying security, see Rule 13d-3(d)(1).
| Item 5. |
Ownership of Five Percent or Less of a Class.
|
If the statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the
beneficial owner of more than five percent of the class of securities, check the following [ ].
| Item 6. |
Ownership of More than Five Percent on Behalf of Another Person.
|
N/A
| Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
|
N/A
| Item 8. |
Identification and Classification of Members of the Group.
|
N/A
| Item 9. |
Notice of Dissolution of Group.
|
N/A
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of
or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
June 27, 2024
|
|
|
(Date)
|
|
|
RDS PRIVATE CAPITAL II, LP
By: /s/ Ronald D. Schmeichel
Ronald D. Schmeichel |
|
|
/s/ Ronald D. Schmeichel
Ronald D. Schmeichel |
JOINT FILING AGREEMENT
Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the
rules and regulations thereunder, each party hereto hereby agrees to the joint filing, on behalf of each of them, of any filing required by such party under Section 13 of the Exchange Act or any rule or regulation thereunder (including any amendment,
restatement, supplement, and/or exhibit thereto) with the Securities and Exchange Commission (and, if such security is registered on a national securities exchange, also with the exchange), and further agrees to the filing, furnishing, and/or
incorporation by reference of this agreement as an exhibit thereto. This agreement shall remain in full force and effect until revoked by any party hereto in a signed writing provided to each other party hereto, and then only with respect to such
revoking party.
IN WITNESS WHEREOF, each party hereto, being duly authorized, has caused this agreement to be executed and effective
as of the date set forth below.
|
June 27, 2024
|
|
|
(Date)
|
|
|
RDS PRIVATE CAPITAL II, LP
By: /s/ Ronald D. Schmeichel
Ronald D. Schmeichel |
|
|
/s/ Ronald D. Schmeichel
Ronald D. Schmeichel |